Company / Debt per Share
Charles River Laboratories Debt per Share History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$33.98
FY2018
5-year range
-
FY2016-FY2018
Trend
+48.1%
vs FY2017
Sector context
#25 of 98
Health Care
What the data says
At $33.98, Charles River Laboratories's debt per share ranks #74 of 98 in the Health Care sector. Increased from $25.28 to $33.98 over the past 2 years.
Based on SEC 10-K filings.
33.98 in FY2018. Top quartile in the Health Care sector.
Increased from $25.28 to $33.98 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 98 in Health CareTop 74% of 98This company $33.98 Sector average $46.44
▼
-26.8% below sector average
Key checks
Key Insights
- In FY2018, debt per share increased 48.1% year-over-year.
- Ranks #25 out of 98 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $33.98 | +48.1% |
| FY2017 | $22.93 | -9.3% |
| FY2016 | $25.28 | +46.9% |
As of FY2018 · SEC 10-K · Updated Jul 4, 2026